Schonfeld Strategic Advisors’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-15,538
| Closed | -$37.3K | – | 2369 |
|
2024
Q2 | $37.3K | Sell |
15,538
-2,887
| -16% | -$6.93K | ﹤0.01% | 1823 |
|
2024
Q1 | $90.7K | Buy |
18,425
+14,962
| +432% | +$73.6K | ﹤0.01% | 1670 |
|
2023
Q4 | $14.5K | Sell |
3,463
-7,975
| -70% | -$33.3K | ﹤0.01% | 1617 |
|
2023
Q3 | $172K | Buy |
11,438
+4,638
| +68% | +$69.8K | ﹤0.01% | 1305 |
|
2023
Q2 | $199K | Buy |
+6,800
| New | +$199K | ﹤0.01% | 1510 |
|
2021
Q3 | – | Sell |
-1,138
| Closed | -$150K | – | 2397 |
|
2021
Q2 | $150K | Sell |
1,138
-122
| -10% | -$16.1K | ﹤0.01% | 1695 |
|
2021
Q1 | $168K | Buy |
+1,260
| New | +$168K | ﹤0.01% | 1519 |
|